Search results
The FTC Move Against Scott Sheffield Goes Too Far
Forbes· 16 hours agoNow, the pendulum is swinging the other way, at least at the Federal Trade Commission, where regulatory scrutiny has increased under President Biden. The...
Should Amazon Still Be Worried About FTC-FCC Probe After A Stellar Q1? Expert Says It Is Just 'A Lot...
Benzinga· 2 days agoDespite a strong first quarter in 2024, Amazon Inc. AMZN finds itself under the microscope of the...
What Will Warren Buffett Bet on Next?
New York Times· 10 hours agoBerkshire Hathaway shareholders will gather in Omaha for the conglomerate’s annual meeting on Saturday, with questions about the company’s future. Tens...
Biden Administration Tells Employers to Stop Shackling Workers With ‘Noncompete Agreements’
Skanner· 4 days agoPresident Joe Biden expressed concern about the oppressive nature of noncompete contracts in July 2021. The U.S. Chamber of Commerce and other business groups sued the government ...
Exxon Set to Win FTC Approval for $60 Billion Pioneer Deal
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- The US Federal Trade Commission is poised to greenlight Exxon Mobil Corp.’s $60...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
NBC Washington· 3 days agoFederal regulators are challenging patents on 20 brand name drugs, including the blockbuster...
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
KSAN - KLST San Angelo· 3 days agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand-name drugs, including the...
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
CNBC· 3 days agoThe Federal Trade Commission on Tuesday said it is challenging hundreds of alleged "junk" patents...
Exxon to Close Pioneer Deal | Transport Topics
Transport Topics· 1 day agoThe decision, announced May 2 in a filing, will ease concern theBiden administration will seek to block a series of oil and gas megamergers, but it came...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Associated Press via Yahoo News· 3 days agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...
